ETNPPL and gastric cancer: Our study showed that AGPAT9 and ETNPPL were down-regulated in patients with GC and participated in the regulation of GPL metabolism, and the protein expression of AGPAT9 and ETNPPL was lower in GC than in normal tissues, which is consistent with other studies.